It has seemed to have been an eternity since the FDA placed rg-101 on a clinical hold. Regulus has stated they will provide a complete response letter to all of the questions and information requested by the FDA early in the fourth quarter 2016. The FDA then has thirty days to respond to the companies […]
↧